Population Pharmacokinetic Analysis of Asunaprevir in Subjects with Hepatitis C Virus Infection

Li Zhu,Hanbin Li,Phyllis Chan,Timothy Eley,Yash Gandhi,Marc Bifano,Mayu Osawa,Takayo Ueno,E. Hughes,Malaz AbuTarif,Richard Bertz,Tushar Garimella

Population Pharmacokinetic Analysis of Asunaprevir in Subjects with Hepatitis C Virus Infection

2018

Li Zhu
Hanbin Li
Phyllis Chan
Timothy Eley
Yash Gandhi
Marc Bifano
Mayu Osawa
Takayo Ueno
E. Hughes
Malaz AbuTarif
Richard Bertz
Tushar Garimella

Introduction Asunaprevir (ASV) is a potent, pangenotypic, twice-daily hepatitis C virus (HCV) NS3 inhibitor indicated for the treatment of chronic HCV infection.

Keywords:

DIRECT ACTING ANTIVIRALS
Intensive care medicine
Hepatitis C virus
Virology
Population
NS3
Pharmacokinetics
Medicine
Asunaprevir
pharmacokinetic analysis
population pharmacokinetics

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations